Stanford
University
  • Stanford Home
  • Maps & Directions
  • Search Stanford
  • Emergency Info
  • Terms of Use
  • Privacy
  • Copyright
  • Trademarks
  • Non-Discrimination
  • Accessibility
© Stanford University.  Stanford, California 94305.
Smart Start—Designing Powerful Clinical Trials Using Pilot Study Data | Stanford HAI
Navigate
  • About
  • Events
  • AI Glossary
  • Careers
  • Search
Participate
  • Get Involved
  • Support HAI
  • Contact Us

Stay Up To Date

Get the latest news, advances in research, policy work, and education program updates from HAI in your inbox weekly.

Sign Up For Latest News

Skip to content
  • About

    • About
    • People
    • Get Involved with HAI
    • Support HAI
    • Subscribe to Email
  • Research

    • Research
    • Research Programs
    • Grants
    • Marlowe (opens in new tab)
    • Student Affinity Groups
    • Centers & Labs
    • Research Publications
    • Research Partners
  • Education

    • Education
    • Executive and Professional Education
    • Government and Policymakers
    • K-12
    • Stanford Students
  • Policy

    • Policy
    • Policy Publications
    • Policymaker Education
    • Student Opportunities
  • AI Index

    • AI Index
    • AI Index Report
    • Global Vibrancy Tool
    • People
  • News
  • Events
  • Industry
  • Centers & Labs
research

Smart Start—Designing Powerful Clinical Trials Using Pilot Study Data

Date
January 22, 2024
Topics
Healthcare
Your browser does not support the video tag.
Read Paper
abstract

BACKGROUND

Digital health interventions may be optimized before evaluation in a randomized clinical trial. Although many digital health interventions are deployed in pilot studies, the data collected are rarely used to refine the intervention and the subsequent clinical trials.

METHODS

We leverage natural variation in patients eligible for a digital health intervention in a remote patient-monitoring pilot study to design and compare interventions for a subsequent randomized clinical trial.

RESULTS

Our approach leverages patient heterogeneity to identify an intervention with twice the estimated effect size of an unoptimized intervention.

CONCLUSIONS

Optimizing an intervention and clinical trial based on pilot data may improve efficacy and increase the probability of success. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT04336969.)

Share
Link copied to clipboard!
Authors
  • Johannes Ferstad
  • Priya Prahalad
    Priya Prahalad
  • Dessi P Zaharieva
  • Emily Fox
    Emily Fox
  • Manisha Desai
    Manisha Desai
  • Ramesh Johari
    Ramesh Johari
  • David Scheinker
    David Scheinker
  • David Maahs
    David Maahs

Related Publications

The Healthcare Policies of the November 2026 Candidates
David Scheinker, Kevin Schulman, Anton Backer, Maya Shah
Quick ReadOct 20, 2026
Research
Your browser does not support the video tag.

Recent polls show that healthcare costs are a top affordability concern for American adults and that a large majority of adults, 90% of Democrats and 75% of Republicans, support a fundamental redesign or major changes to our healthcare system. Across states, political parties, and different types of office, politicians and constituents hold different views on healthcare policies and support different proposals. Various stakeholders such as patients, physicians, nurses, veterans, employers, and industry groups could potentially benefit from access to data on how their representatives’ views align with their own. There is no systematic, openly available database and analysis of these views. We sought to create the first systematic, openly available database and analysis of the healthcare policies and proposals of the leading candidates in the November 2026 elections and beyond.

Research
Your browser does not support the video tag.

The Healthcare Policies of the November 2026 Candidates

David Scheinker, Kevin Schulman, Anton Backer, Maya Shah
HealthcareRegulation, Policy, GovernanceQuick ReadOct 20

Recent polls show that healthcare costs are a top affordability concern for American adults and that a large majority of adults, 90% of Democrats and 75% of Republicans, support a fundamental redesign or major changes to our healthcare system. Across states, political parties, and different types of office, politicians and constituents hold different views on healthcare policies and support different proposals. Various stakeholders such as patients, physicians, nurses, veterans, employers, and industry groups could potentially benefit from access to data on how their representatives’ views align with their own. There is no systematic, openly available database and analysis of these views. We sought to create the first systematic, openly available database and analysis of the healthcare policies and proposals of the leading candidates in the November 2026 elections and beyond.

Roles for AI in Implementation of Medicaid Work Requirements
Michelle Mello, Himaja Nagireddy
Quick ReadSep 03, 2026
Research
Your browser does not support the video tag.

By January 2027, 44 state Medicaid programs must redetermine the eligibility of millions of beneficiaries under criteria in the 2025 budget reconciliation law (HR 1). Among the changes are “community engagement” (work) requirements and increased redetermination cadence (from annual to at least semiannual). In preparation, state Medicaid agencies have been exploring technological solutions to automate redeterminations at scale, including artificial intelligence (AI). Six agencies have decided to use AI tools so far and 21 states are considering use of them. Strategic deployment of AI can help states tackle the redetermination juggernaut, but overly broad or hasty deployment could compound the harms of HR 1.

Research
Your browser does not support the video tag.

Roles for AI in Implementation of Medicaid Work Requirements

Michelle Mello, Himaja Nagireddy
HealthcareRegulation, Policy, GovernanceQuick ReadSep 03

By January 2027, 44 state Medicaid programs must redetermine the eligibility of millions of beneficiaries under criteria in the 2025 budget reconciliation law (HR 1). Among the changes are “community engagement” (work) requirements and increased redetermination cadence (from annual to at least semiannual). In preparation, state Medicaid agencies have been exploring technological solutions to automate redeterminations at scale, including artificial intelligence (AI). Six agencies have decided to use AI tools so far and 21 states are considering use of them. Strategic deployment of AI can help states tackle the redetermination juggernaut, but overly broad or hasty deployment could compound the harms of HR 1.

Addressing Medical Affordability Without Compromising Care
Kevin Schulman, Ezekiel J. Emanuel, MD, PhD
Quick ReadJul 09, 2026
Research
Your browser does not support the video tag.

The US spends 25 percent of all health care costs on administration, a big part of which involves billing for medical services. To realize savings requires standardizing and digitizing billing.

Research
Your browser does not support the video tag.

Addressing Medical Affordability Without Compromising Care

Kevin Schulman, Ezekiel J. Emanuel, MD, PhD
HealthcareRegulation, Policy, GovernanceQuick ReadJul 09

The US spends 25 percent of all health care costs on administration, a big part of which involves billing for medical services. To realize savings requires standardizing and digitizing billing.

Utah's Experiment With AI-Driven Prescription Renewals
Michelle Mello
Quick ReadMar 19, 2026
Research
Your browser does not support the video tag.

In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions. Although physicians will initially validate the AI’s actions, the pilot program will swiftly become one of the first deployments at scale of an autonomous, agentic system in medicine. The announcement prompted concern from associations of physicians and pharmacists who opined that AI “should NOT be making care decisions.”

Research
Your browser does not support the video tag.

Utah's Experiment With AI-Driven Prescription Renewals

Michelle Mello
HealthcareRegulation, Policy, GovernanceQuick ReadMar 19

In January 2026, Utah announced a first-of-its kind pilot program allowing an autonomous artificial intelligence (AI) agent to renew prescriptions for consumers who request it. The state agreed not to enforce its unprofessional conduct laws against the developer, Doctronic, if the company adheres to a contract that includes safety and privacy protections. The pilot program includes 192 drugs for chronic conditions. Although physicians will initially validate the AI’s actions, the pilot program will swiftly become one of the first deployments at scale of an autonomous, agentic system in medicine. The announcement prompted concern from associations of physicians and pharmacists who opined that AI “should NOT be making care decisions.”